Glycated serum proteins and glucose tolerance

Area of Science:

• Clinical Chemistry
• Endocrinology
• Metabolic Disorders

Background:

• Glycated proteins, including glycated hemoglobin (HbA1c) and glycated serum proteins (GSP), are used as biomarkers for glucose control.
• Assessing glucose metabolism involves evaluating various metabolic parameters and glucose tolerance levels.

Purpose of the Study:

• To compare the efficacy of Glycated serum proteins (GSP) and glycated hemoglobin (HbA1c) in assessing glucose tolerance.
• To evaluate the correlation of GSP and HbA1c with metabolic parameters across different glucose tolerance groups.

Main Methods:

• Evaluation of GSP and HbA1c levels in 120 subjects across four groups: normal glucose tolerance (NGT), impaired glucose tolerance (IGT), non-insulin-dependent diabetes mellitus (NIDD), and insulin-dependent diabetes mellitus (IDD).
• Analysis of metabolic parameters and comparison of GSP and HbA1c performance in differentiating these groups.

Main Results:

• GSP levels were significantly elevated in IGT, NIDD, and IDD groups compared to the NGT group.
• HbA1c levels showed significant increases only in NIDD and IDD groups compared to NGT and IGT groups.
• GSP demonstrated a stronger correlation with metabolic parameters and less overlap between groups than HbA1c, although GSP could not reliably distinguish IGT from NGT.

Conclusions:

• GSP assays are effective in differentiating between normal and diabetic glucose tolerance.
• GSP assays alone are insufficient to distinguish between normal and impaired glucose tolerance.
• GSP may offer advantages over HbA1c in certain aspects of glucose metabolism assessment due to better correlation and less group overlap.